Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9337286 | 0.75 | MEN1 (0.40) | MEN1KMT2ALMNAATM | |
| SCHEMBL10952021 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL829197 | 0.73 | MEN1 (0.39) | MEN1KMT2ALMNAATM | |
| SCHEMBL15461040 | 0.72 | LMNA (0.39) | MEN1KMT2ALMNAATM | |
| SCHEMBL17772669 | 0.72 | PDK2 (0.31) | ATAD2PDK2PDK4 | |
| SCHEMBL10195453 | 0.69 | LMNA (0.40) | MEN1KMT2ALMNA | |
| SCHEMBL11772318 | 0.69 | LMNA (0.40) | LMNA | |
| SCHEMBL15458746 | 0.69 | — | — | |
| Metharbital SCHEMBL78867 | 0.69 | ATM (0.60) | MEN1KMT2ALMNAATM | |
| SCHEMBL14275081 | 0.68 | ATAD2 (0.31) | LMNAATAD2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7863264-B2 | Stabilised compositions having antibacterial activity | COLOPLAST A/S (DK) | 2011-01-04 | — | — | US | claimed |
| WO-2008122596-A2 | CURABLE THERAPEUTIC IMPLANT COMPOSITION | CINVENTION AG (DE) | 2008-10-16 | — | — | WO | claimed |
| US-20080248086-A1 | CURABLE THERAPEUTIC IMPLANT COMPOSITION | CINVENTION AG (DE) | 2008-10-09 | — | — | US | claimed |
| EP-0438123-B1 | Near infrared polymerization initiator | SHOWA DENKO KK (JP) | 1995-09-13 | — | — | EP | claimed |
| EP-0438123-A2 | Near infrared polymerization initiator | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1991-07-24 | — | — | EP | claimed |
| JP-4261405-A | — | — | None | — | — | JP | disclosed |
| EP-4032690-B1 | MANUFACTURING METHOD FOR A PROSTHETIC APPARATUS AND MANUFACTURING APPARATUS FOR THE PROSTHETIC APPARATUS | SHOFU KK (JP) | 2025-05-28 | — | — | EP | disclosed |
| EP-3042645-B2 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2025-03-12 | — | — | EP | disclosed |
| EP-3479812-B1 | RESIN CURED BODY FOR DENTAL CUTTING PROCESSING IMPROVED IN ADHESIVE PROPERTY | SHOFU INC (JP) | 2025-03-05 | — | — | EP | disclosed |
| US-12194684-B2 | Post-curing method after optical shaping of 3D printer | KABUSHIKI KAISHA SHOFU (JP) | 2025-01-14 | — | — | US | disclosed |
| US-20220387264-A1 | DENTAL PHOTOCURABLE COMPOSITION EXCELLENT IN STORAGE STABILITY | SHOFU INC. (JP) | 2022-12-08 | — | — | US | disclosed |
| US-20220347927-A1 | POST-CURING METHOD AFTER OPTICAL SHAPING OF 3D PRINTER | KABUSHIKI KAISHA SHOFU (JP) | 2022-11-03 | — | — | US | disclosed |
| US-4636453-A | Photopolymer films containing microencapsulated sensitometric adjuvants | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-01-13 | — | — | US | disclosed |
| EP-0103294-B1 | N-ALKYLINDOLYLIDENE AND N-ALKYLBENZOTHIAZOLYLIDENE ALKANONES AS SENSITIZERS FOR PHOTOPOLYMER COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-12-30 | — | — | EP | disclosed |
| US-4565769-A | Polymeric sensitizers for photopolymer composition | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-01-21 | — | — | US | disclosed |
| US-4555473-A | ETHYLENICALLY UNSATURATED MONOMER, PHOTOINITIATOR, BINDER | E. I. DUPONT DE NEMOURS AND COMPANY (US) | 1985-11-26 | — | — | US | disclosed |
| US-4535052-A | HIGH SPEED PHOTORESISTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-08-13 | — | — | US | disclosed |
| EP-0127762-A1 | Constrained N-alkylamino aryl ketones as sensitizers for photopolymer compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-12-12 | — | — | EP | disclosed |
| US-4454218-A | WITH UNSATURATED COMPOUND AND PHOTOINITIATOR | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-06-12 | — | — | US | disclosed |
| EP-0103294-A1 | N-alkylindolylidene and N-alkylbenzothiazolylidene alkanones as sensitizers for photopolymer compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-03-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220387264-A1 | DENTAL PHOTOCURABLE COMPOSITION EXCELLENT IN STORAGE STABILITY | H1-0, POLA1, H1-2 | MEN1 714/4885KMT2A 1832/4885LMNA 92/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.